111 related articles for article (PubMed ID: 10772639)
1. Dose-dependent pharmacokinetics of cyclosporin A in rats: events in tissues.
Tanaka C; Kawai R; Rowland M
Drug Metab Dispos; 2000 May; 28(5):582-9. PubMed ID: 10772639
[TBL] [Abstract][Full Text] [Related]
2. Physiologically based pharmacokinetics of cyclosporine A: extension to tissue distribution kinetics in rats and scale-up to human.
Kawai R; Mathew D; Tanaka C; Rowland M
J Pharmacol Exp Ther; 1998 Nov; 287(2):457-68. PubMed ID: 9808668
[TBL] [Abstract][Full Text] [Related]
3. Effect of cyclosporine A on the tissue distribution and pharmacokinetics of etoposide.
Cárcel-Trullols J; Torres-Molina F; Araico A; Saadeddin A; Peris JE
Cancer Chemother Pharmacol; 2004 Aug; 54(2):153-60. PubMed ID: 15114410
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, blood partition, and tissue distribution of itraconazole.
Lee JH; Shin JH; Lee MG
Res Commun Mol Pathol Pharmacol; 2004; 115-116():203-15. PubMed ID: 17564318
[TBL] [Abstract][Full Text] [Related]
6. Cremophor EL releases cyclosporin A adsorbed on blood cells and blood vessels, and increases apparent plasma concentration of cyclosporin A.
Jin M; Shimada T; Yokogawa K; Nomura M; Mizuhara Y; Furukawa H; Ishizaki J; Miyamoto K
Int J Pharm; 2005 Apr; 293(1-2):137-44. PubMed ID: 15778051
[TBL] [Abstract][Full Text] [Related]
7. Effect of gonadectomy on cyclosporine pharmacokinetics in male and female rats.
Molpeceres J; Chacón M; Aberturas MR; Guzmán M; Díez ML; Rodriguez-Puyol M
Pharmazie; 2001 Jan; 56(1):78-82. PubMed ID: 11210676
[TBL] [Abstract][Full Text] [Related]
8. Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteers.
Kees F; Bucher M; Schweda F; Gschaidmeier H; Burhenne J; Mikus G; Faerber L
Ther Drug Monit; 2006 Jun; 28(3):312-20. PubMed ID: 16778713
[TBL] [Abstract][Full Text] [Related]
9. The effect of increased lipoprotein levels on the pharmacokinetics of cyclosporine A in the laboratory rat.
Brocks DR; Ala S; Aliabadi HM
Biopharm Drug Dispos; 2006 Jan; 27(1):7-16. PubMed ID: 16278928
[TBL] [Abstract][Full Text] [Related]
10. Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.
Liu J; Kraut EH; Balcerzak S; Grever M; D'Ambrosio S; Chan KK
Cancer Chemother Pharmacol; 2002 Dec; 50(6):445-53. PubMed ID: 12451470
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, blood partition and protein binding of DA-7867, a new oxazolidinone.
Bae SK; Chung WS; Kim EJ; Rhee JK; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2004 Apr; 25(3):127-35. PubMed ID: 15083501
[TBL] [Abstract][Full Text] [Related]
12. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
Yang ZQ; Xu J; Pan P; Zhang XN
Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
[TBL] [Abstract][Full Text] [Related]
13. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
[TBL] [Abstract][Full Text] [Related]
14. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
Sibbald C; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and tissue distribution of d-alpha-tocopheryl succinate formulations following intravenous administration in the rat.
Teng XW; Davies NM; Fukuda C; Good RL; Fariss MW
Biopharm Drug Dispos; 2005 Jul; 26(5):195-203. PubMed ID: 15900617
[TBL] [Abstract][Full Text] [Related]
16. [Relative bioavailability of cyclosporine A-loaded hydroxypropyl methylcellulose phthalate nanoparticles for oral administration in rats].
Wang XQ; Dai JD; Zhang Q; Zhang T; Xia GM
Yao Xue Xue Bao; 2004 Jun; 39(6):463-6. PubMed ID: 15491107
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based pharmacokinetics of cyclosporine A: reevaluation of dose-nonlinear kinetics in rats.
Tanaka C; Kawai R; Rowland M
J Pharmacokinet Biopharm; 1999 Dec; 27(6):597-623. PubMed ID: 11153448
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and dose proportionality of BMS-204352 after intraarterial administration to rats.
Krishna R; Shah VR; Srinivas N
Biopharm Drug Dispos; 2002 Sep; 23(6):233-7. PubMed ID: 12214323
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]